Igor Livshits
R&D director
Igor Livshits is Noya Therapeutics’ Director of R&D, bringing to the company his rich background in healthcare and pharmaceutical management that spans over two decades.
His career began with a focus on immunology and rheumatology. As Business Unit Manager at EGIS Biologicals, Mr. Livshits successfully launched several advanced products, capturing a 30% market share within a year, and achieved a 50% market share for a critical product from the first year.
His strategic leadership in sales and marketing at Grunenthal resulted in a 30% sales increase across the portfolio, showcasing his ability to drive growth and market penetration. At Ebewe Pharma/Sandoz, he developed the oncology and rheumatology business from the ground up, achieving market leadership within a year.
Prior to his current role, Mr. Livshits was an independent consultant at Clalit Healthcare, an integrated insurer-provider covering over half the population of Israel. He contributed to the development of generic pharmaceuticals, showing expertise in R&D, clinical trials, and market access strategies.
